Upendra Sharma

The pharmaceutical industry plays a vital role in protecting human life and health. Medicines, vaccines and healthcare products directly impact millions of people around the world. Because of this, pharmaceutical companies must operate ethically and responsibly and social due diligence is becoming increasingly important. Social due diligence helps pharmaceutical companies identify, assess and manage social risks related to people, communities and ethical practices. It ensures that business operations respect human rights, employee welfare, patient safety and community well-being. Understanding social due diligence Social due diligence is a structured process used to evaluate how a company’s activities affect people. It focuses on social risks such as unsafe working conditions, unfair labour practices, community health impacts, and ethical issues in clinical trials and supply chains. In the pharmaceutical industry, where trust is critical, social due diligence is essential to maintain transparency, compliance and long-term sustainability. Why social due diligence is critical in the pharmaceutical industry 1. Protecting human rights and worker safety Pharmaceutical manufacturing involves chemical handling, laboratory work and high-risk processes. Social due diligence ensures: Safe working conditions. Fair wages and working hours. Protection from workplace hazards. This helps prevent accidents and promotes employee well-being. 2. Ethical clinical trials and ersearch Clinical trials involve human participants. Social due diligence ensures: Informed consent is properly taken. Participants are treated ethically. Vulnerable groups are protected. Ethical research practices build public trust and meet international standards. 3. Responsible supply chain management Pharmaceutical companies rely on global suppliers for raw materials and active ingredients. Social due diligence helps identify risks such as: Child or forced labour. Poor working conditions. Human rights violations. Monitoring suppliers ensures ethical sourcing and compliance. 4. Community health and social impact Manufacturing plants and research facilities affect nearby communities. Social due diligence evaluates: Community health risks. Access to healthcare. Social disruptions caused by operations. This helps companies reduce negative impacts and support local development. Key elements of social due diligence in pharmaceutical companies Employee welfare assessment This includes reviewing labour policies, safety standards, training programmes and grievance mechanisms to ensure employees are treated fairly and respectfully. Stakeholder engagement Engaging with employees, patients, regulators and local communities helps identify concerns early and improves decision-making. Risk identification and mitigation Social risks can be identified through audits, assessments and surveys. Companies can then create action plans to reduce or eliminate these risks. Compliance with regulations and standards Social due diligence ensures compliance with: National labour laws. International human rights standards. Industry-specific guidelines. Benefits of social due diligence for pharmaceutical companies Builds trust with patients and regulators. Reduces legal and reputational risks. Improves employee morale and productivity. Supports sustainable and ethical growth. Enhances brand credibility in global markets. Companies that invest in social due diligence are better prepared to face regulatory challenges and social expectations. Conclusion Social due diligence in the pharmaceutical industry is not just a regulatory requirement—it is a moral responsibility. By focusing on people, ethics and transparency, pharmaceutical companies can ensure safe operations, protect human rights and contribute positively to society. In an industry where human lives are at stake, responsible practices create long-term value and sustainable success. Social due diligence helps pharmaceutical companies move forward with integrity, accountability and trust.